Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP648532.RA5wrgH6FJwDLq5VW2IiLtEv7lmS_Ej4T8V878X3OFYWc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP648532.RA5wrgH6FJwDLq5VW2IiLtEv7lmS_Ej4T8V878X3OFYWc130_assertion type Assertion NP648532.RA5wrgH6FJwDLq5VW2IiLtEv7lmS_Ej4T8V878X3OFYWc130_head.
- NP648532.RA5wrgH6FJwDLq5VW2IiLtEv7lmS_Ej4T8V878X3OFYWc130_assertion description "[Proportions of XPD codon 312( *)GG/GA/AA, XPD codon 751( *)TT/TG/GG, and XPD promoter -114( *)GG/GC/CC were [1] 65%/22.5%/12.5%, 92.5%/6.7%/0.8%, and 22.5%/46.7%/30.8%; and [2] 64.3%/22.3%/13.4%, 92%/7.1%/0.9%, and 23.2%/46.4%/30.4%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648532.RA5wrgH6FJwDLq5VW2IiLtEv7lmS_Ej4T8V878X3OFYWc130_provenance.
- NP648532.RA5wrgH6FJwDLq5VW2IiLtEv7lmS_Ej4T8V878X3OFYWc130_assertion evidence source_evidence_literature NP648532.RA5wrgH6FJwDLq5VW2IiLtEv7lmS_Ej4T8V878X3OFYWc130_provenance.
- NP648532.RA5wrgH6FJwDLq5VW2IiLtEv7lmS_Ej4T8V878X3OFYWc130_assertion SIO_000772 18177646 NP648532.RA5wrgH6FJwDLq5VW2IiLtEv7lmS_Ej4T8V878X3OFYWc130_provenance.
- NP648532.RA5wrgH6FJwDLq5VW2IiLtEv7lmS_Ej4T8V878X3OFYWc130_assertion wasDerivedFrom befree-2016 NP648532.RA5wrgH6FJwDLq5VW2IiLtEv7lmS_Ej4T8V878X3OFYWc130_provenance.
- NP648532.RA5wrgH6FJwDLq5VW2IiLtEv7lmS_Ej4T8V878X3OFYWc130_assertion wasGeneratedBy ECO_0000203 NP648532.RA5wrgH6FJwDLq5VW2IiLtEv7lmS_Ej4T8V878X3OFYWc130_provenance.